跳至主要内容
临床试验/NL-OMON50641
NL-OMON50641已完成不适用

A Randomized Controlled Trial on Prophylactic Platelet Transfusion Prior to Central Venous Catheter Placement in Patients with Thrombocytopenia - PACER trial

Academisch Medisch Centrum0 个研究点目标入组 392 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
392

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age>18 years
  • 2. Need for CVC placement at the clinician*s discretion
  • 3. Platelet count between 10*50x109/L
  • 4. INR*3.0
  • 5. Informed consent

排除标准

  • 1. Use of therapeutic anticoagulant therapy, except single antiplatelet therapy
  • 2. Contra-indication for PC transfusion, such Thrombotic thrombocytopenic
  • purpura, or Congenital IgA deficiency.
  • 3. Randomization in the current trial, in the previous 24 hours.
  • 4. Patients with a history of congenital or acquired coagulation factor
  • deficiency or bleeding diathesis.

研究者

相似试验